XCUR
NASDAQ
$1.89
Exicure Inc (XCUR)
Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. The company is headquartered in Chicago, Illinois.
Sector:
Healthcare
Industry:
Biotechnology
Target: $2 (+5.82%)
Market Cap
$10M
Free Cash Flow Yield
-84.62%
Beta (5Y)
0.49
Price Chart
Valuation
Market Cap$10M
P/S13.61
P/B5.16
Profitability
Gross Profit (TTM)-$3.29M
EBITDA-$10M
EPS-$1.54
Financial Health
Free Cash Flow Yield-84.62%
Growth & Risk
FCF 5Y CAGR-12.54%
Beta (5Y)0.49
Sharpe Ratio-0.73